Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 117040
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.117040
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.117040
Table 1 Demographic and clinical characteristics of the study groups, n (%)/mean ± SD
| Parameter | Group I (n = 31) | Group II (n = 31) | Group III (n = 31) | P value1 |
| Age (years) | 57 ± 9.46 | 60 ± 6.59 | 56 ± 6.52 | 0.06 |
| FIB-4 index | 4.5 ± 1.2 | 4.3 ± 1.1 | NA | 0.48 |
| APRI score | 2.1 ± 0.7 | 1.9 ± 0.6 | NA | 0.25 |
| Sex (male/female) | 22/9 | 19/12 | 14/17 | 0.08 |
| Child-Pugh score | < 0.001 | |||
| Class A | 7 (22.6) | 9 (29.1) | ||
| Class B | 18 (58.0) | 17 (54.8) | ||
| Class C | 6 (19.4) | 5 (16.1) |
- Citation: Othman AAA, Elsharkawy L, Saleh MW, Mohamed MM, Elsayed FMA. Multimarker model for non-invasive assessment of variceal bleeding in chronic hepatitis C cirrhotic patients. World J Hepatol 2026; 18(3): 117040
- URL: https://www.wjgnet.com/1948-5182/full/v18/i3/117040.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i3.117040